- Home
- STRO vs FEAM Comparison
STRO vs FEAM Comparison
Compare STRO & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- FEAM
- Stock Information
- Founded
- STRO 2003
- FEAM 2016
- Country
- STRO United States
- FEAM United States
- Employees
- STRO N/A
- FEAM N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- FEAM Major Chemicals
- Sector
- STRO Health Care
- FEAM Industrials
- Exchange
- STRO Nasdaq
- FEAM Nasdaq
- Market Cap
- STRO 76.5M
- FEAM 78.3M
- IPO Year
- STRO 2018
- FEAM N/A
- Fundamental
- Price
- STRO $0.91
- FEAM $3.98
- Analyst Decision
- STRO Hold
- FEAM Strong Buy
- Analyst Count
- STRO 7
- FEAM 2
- Target Price
- STRO $1.97
- FEAM $7.25
- AVG Volume (30 Days)
- STRO 480.6K
- FEAM 98.0K
- Earning Date
- STRO 11-12-2025
- FEAM 11-12-2025
- Dividend Yield
- STRO N/A
- FEAM N/A
- EPS Growth
- STRO N/A
- FEAM N/A
- EPS
- STRO N/A
- FEAM N/A
- Revenue
- STRO $104,473,000.00
- FEAM N/A
- Revenue This Year
- STRO $65.48
- FEAM N/A
- Revenue Next Year
- STRO N/A
- FEAM $17,100.00
- P/E Ratio
- STRO N/A
- FEAM N/A
- Revenue Growth
- STRO N/A
- FEAM N/A
- 52 Week Low
- STRO $0.52
- FEAM $2.82
- 52 Week High
- STRO $4.60
- FEAM $24.84
- Technical
- Relative Strength Index (RSI)
- STRO 52.61
- FEAM 55.31
- Support Level
- STRO $0.84
- FEAM $3.31
- Resistance Level
- STRO $0.95
- FEAM $3.85
- Average True Range (ATR)
- STRO 0.06
- FEAM 0.26
- MACD
- STRO -0.00
- FEAM -0.00
- Stochastic Oscillator
- STRO 65.42
- FEAM 79.76
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.